The STRIDER trials: ongoing research

Wessel Ganzevoort; Christian Gluud; Ken Lim; Ben Mol; Katie Groom

doi:10.1016/S2352-4642(18)30036-1

The STRIDER trials: ongoing research

Wessel Ganzevoort^* (Corresponding Author), Christian Gluud, Ken Lim, Ben Mol, Katie Groom

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	e3
Number of pages	1
Journal	The Lancet Child and Adolescent Health
Volume	2
Issue number	3
Early online date	13 Feb 2018
DOIs	https://doi.org/10.1016/S2352-4642(18)30036-1
Publication status	Published - Mar 2018

Bibliographical note

Refers to:

Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A Turner, Louise C Kenny, Philip N Baker, Edward D Johnstone, Asma Khalil, Peter von Dadelszen, Aris T Papageorghiou, Zarko Alfirevic

Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial

The Lancet Child & Adolescent Health, Volume 2, Issue 2, February 2018, Pages 93-102

Access to Document

10.1016/S2352-4642(18)30036-1

Cite this

@article{2d85e5c160744799929a9f7a5bc69d1f,

title = "The STRIDER trials: ongoing research",

author = "Wessel Ganzevoort and Christian Gluud and Ken Lim and Ben Mol and Katie Groom",

note = "Refers to: Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A Turner, Louise C Kenny, Philip N Baker, Edward D Johnstone, Asma Khalil, Peter von Dadelszen, Aris T Papageorghiou, Zarko Alfirevic Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial The Lancet Child & Adolescent Health, Volume 2, Issue 2, February 2018, Pages 93-102",

year = "2018",

month = mar,

doi = "10.1016/S2352-4642(18)30036-1",

language = "English",

volume = "2",

pages = "e3",

journal = "The Lancet Child and Adolescent Health",

issn = "2352-4642",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - The STRIDER trials

T2 - ongoing research

AU - Ganzevoort, Wessel

AU - Gluud, Christian

AU - Lim, Ken

AU - Mol, Ben

AU - Groom, Katie

N1 - Refers to: Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A Turner, Louise C Kenny, Philip N Baker, Edward D Johnstone, Asma Khalil, Peter von Dadelszen, Aris T Papageorghiou, Zarko Alfirevic Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial The Lancet Child & Adolescent Health, Volume 2, Issue 2, February 2018, Pages 93-102

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85042008009&partnerID=8YFLogxK

U2 - 10.1016/S2352-4642(18)30036-1

DO - 10.1016/S2352-4642(18)30036-1

M3 - Letter

C2 - 30169258

AN - SCOPUS:85042008009

SN - 2352-4642

VL - 2

SP - e3

JO - The Lancet Child and Adolescent Health

JF - The Lancet Child and Adolescent Health

IS - 3

ER -

The STRIDER trials: ongoing research

Bibliographical note

Access to Document

Other files and links

Cite this